Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial

NCT07486206 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

152

Enrollment

OTHER

Sponsor class

Conditions

Interstitial Lung Disease (ILD)
Fibrotic Interstitial Lung Disease
Idiopathic Pulmonary Fibrosis (IPF)
Progressive Pulmonary Fibrosis
Interstitial Lung Disease Due to Connective Tissue Disease (Disorder)

Interventions

OTHER: Standard ILD Follow-Up Pathway
OTHER: Optimized One-Day ILD Follow-Up Circuit

Sponsor

Hospital de Granollers